NEVVI Medicare utilization intelligence
CMS RBCS · Treatments · Injections and Infusions (nononcologic)

Injection - Anticoagulant codes

6 CPT®/HCPCS codes, ranked by est. all-Medicare services — scaled from national Medicare Part B fee-for-service volume. Open any code for the full market view — ranked physician groups, geography, and 12-year trend.

CY2024 · National scale is an all-Medicare estimate · est. — scaled estimate — assumes MA utilization mirrors FFS; not an observation; the observed fee-for-service figure is shown adjacent. Part B · national figures

HCPCS · Treatment J0585 Injection, onabotulinumtoxina, 1 unit CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 93.96M services · est. ▲ 10.1% YoY · 108,819 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 46.38M observed fee-for-service services
See the national market for J0585 → ranked groups · states · 12-yr trend
HCPCS · Treatment J1642 Injection, heparin sodium, (heparin lock flush), per 10 units CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 568,879 services · est. ▼ 41.4% YoY · 1,346 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 283,739 observed fee-for-service services
See the national market for J1642 → ranked groups · states · 12-yr trend
HCPCS · Treatment J1644 Injection, heparin sodium, per 1000 units CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 499,426 services · est. ▼ 3.4% YoY · 4,629 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 247,119 observed fee-for-service services
See the national market for J1644 → ranked groups · states · 12-yr trend
HCPCS · Treatment J2997 Injection, alteplase recombinant, 1 mg CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 22,717 services · est. ▼ 28.9% YoY · 3,215 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 11,482 observed fee-for-service services
See the national market for J2997 → ranked groups · states · 12-yr trend
HCPCS · Treatment J1650 Injection, enoxaparin sodium, 10 mg CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 9,562 services · est. ▼ 26.5% YoY · 144 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 4,769 observed fee-for-service services
See the national market for J1650 → ranked groups · states · 12-yr trend
HCPCS · Treatment J2720 Injection, protamine sulfate, per 10 mg CMS descriptor · HCPCS
Medicare Part B claims
First observed 2013 — start of our 12-year window; the code predates it
National scale 3,056 services · est. ▼ 11.4% YoY · 405 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 1,395 observed fee-for-service services
See the national market for J2720 → ranked groups · states · 12-yr trend